Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-14 | Jacqualyn A. Fouse, Ph.D. Executive Chair Dermavant Sciences Director since 2017 Age 56 Independent Director Committees None Dr. Fouse has served as Executive Chair of Dermavant Sciences, a biopharmaceutical company, since July 2017. |
| 2019-03-21 | Dr. Fouse has served as Chief Executive Officer of Agios Pharmaceuticals, Inc., a biopharmaceutical company, since February 2019. |
| 2020-04-20 | Jacqualyn A. Fouse, Ph.D. INDEPENDENT DIRECTOR Age: 58 COMMITTEES: Audit and Finance Nominating and Corporate Governance DIRECTOR SINCE: 2017 Dr. Fouse has served as Chief Executive Officer of Agios Pharmaceuticals, Inc. |
| 2021-04-16 | Dr. Fouse has served as Chief Executive Officer of Agios Pharmaceuticals, Inc., a biopharmaceutical company, since February 2019. Prior to Agios, she served as Executive Chair of Dermavant Sciences, a biopharmaceutical company from July 2017 to September 2018. |
| 2022-04-29 | Dr. Fouse has served as Chief Executive Officer of Agios Pharmaceuticals, Inc., a biopharmaceutical company, since February 2019. Prior to Agios, she served as Executive Chair of Dermavant Sciences, a biopharmaceutical company from July 2017 to September 2018. From September 2010 until June 2017, Dr. Fouse served in various capacities at Celgene Corporation, a biopharmaceutical company, serving as Strategic Advisor to the Management Executive Committee from April 2017 to June 2017, President and Chief Operating Officer from March 2016 to March 2017, President, Hematology and Oncology from August 2014 to February 2016, Executive Vice President and Chief Financial Officer from February 2012 to July 2014, and Senior Vice President and Chief Financial Officer from September 2010 to February 2012. Prior to joining Celgene, Dr. Fouse served as Chief Financial Officer of Bunge Limited, a global agribusiness and food company, from July 2007 to September 2010. Prior to joining Bunge, Dr. Fouse served as Senior Vice President, Chief Financial Officer and Corporate Strategy at Alcon Laboratories, Inc. since 2006, and as its Senior Vice President and Chief Financial Officer since 2002. The Board has concluded that Jacqualyn A. Fouse should serve on the Board because she has significant corporate finance, financial reporting and accounting expertise as a result of her executive roles at Agios and previously at Dermavant Sciences and Celgene, as well as her prior positions with other companies. Additionally, Dr. Fouse is able to provide diverse and valuable corporate governance, management, operational and strategic expertise to the Board through her experience as an executive officer and a public company board member. Other Public Company Boards: Current Agios Pharmaceuticals, Inc. Past 5 Years Celgene Corporation (2016-2017) Dick’s Sporting Goods, Inc. (2010-2020) |
| 2023-04-28 | Jacqualyn A. Fouse, Ph.D., Independent Director, Former Chief Executive Officer, Agios Pharmaceuticals, Inc., Age: 61, Director Since: 2017, Committees: Audit and Finance, Nominating and Corporate Governance, 2022 Director Compensation Table: Total $448,968 |
| 2024-04-29 | Jacqualyn A. Fouse, Ph.D. INDEPENDENT DIRECTOR Age: 62 COMMITTEES: Audit and Finance, Nominating and Corporate Governance DIRECTOR SINCE: 2017 |
Data sourced from SEC filings. Last updated: 2025-12-07